Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px
Organisation › Details

GenAhead Bio Inc. (JP)

GenAhead Bio is a new spinout biotechnology company focused on genome editing and nucleic acid delivery. Our headquarters are located in Shonan Health Innovation Park (iPark), in Fujisawa, Japan, which was launched by Takeda Pharmaceutical Company Limited by transforming its Shonan Research Institute to enhance scientific innovation. Through a licensing deal with ERS Genomics, GenAhead Bio has launched CRISPR/Cas9 services to leading pharmaceutical companies and academics to produce cells with precise genetic modifications utilizing high KI efficiency, such as single nucleotide polymorphism (SNP) conversions as a cellular disease model, in any particular mammalian cell line. Regarding induced pluripotent stem (iPS) cells, GenAhead Bio has partnered with ReproCELL Inc., a pioneering company in iPS cell technologies, to deliver GenAhead Bio’s products more expeditiously to the customers in the world. GenAhead Bio has another technology; delivery of nucleic acids to skeletal muscle and heart. It is also applicable to immune cells. In addition to fee-for service, GenAhead Bio envisions a future of research and development partnership with pharmaceutical companies in both fields. *

 

Period Start 2018-02-01 established (s-off)
Products Industry genome editing (gene editing)
  Industry 2 BIOTECH
Person Person Sugo, Tsukasa (GenAhead Bio 201810 CEO)
     
  City n. a. Fujiswawa, Kanagawa
    Address record changed: 2018-10-10
     
Basic data Employees n. a.
     
    * Document for �About Section�: ERS Genomics Ltd.. (10/4/18). "Press Release: GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin.
     
   
Record changed: 2018-10-10

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

More documents for GenAhead Bio Inc. (JP)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top